Search

everythinglearnresearchcommunity

for

Search:↓

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Enhancing immune response can improve cancer treatment effectiveness.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Ayurvedic treatment may improve quality of life for cancer patients undergoing chemo and radiotherapy.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Adipose-derived stem cells help heal radiation skin damage by reducing cell death and inflammation.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Provenge extends prostate cancer survival by about 4 months.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.